These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2001979)

  • 1. Gamma-lactam analogues of beta-lactam antibiotics.
    Baldwin JE; Lynch GP; Pitlik J
    J Antibiot (Tokyo); 1991 Jan; 44(1):1-24. PubMed ID: 2001979
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclobutanone Analogues of β-Lactam Antibiotics: β-Lactamase Inhibitors with Untapped Potential?
    Devi P; Rutledge PJ
    Chembiochem; 2017 Feb; 18(4):338-351. PubMed ID: 27992105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming resistance to β-lactam antibiotics.
    Worthington RJ; Melander C
    J Org Chem; 2013 May; 78(9):4207-13. PubMed ID: 23530949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress toward inhibitors of metallo-β-lactamases.
    McGeary RP; Tan DT; Schenk G
    Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective synthesis of the gamma-lactam hydrolysate of the thiopeptide cyclothiazomycin.
    Bagley MC; Xiong X
    Org Lett; 2004 Sep; 6(19):3401-4. PubMed ID: 15355062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enzymes of β-lactam biosynthesis.
    Hamed RB; Gomez-Castellanos JR; Henry L; Ducho C; McDonough MA; Schofield CJ
    Nat Prod Rep; 2013 Jan; 30(1):21-107. PubMed ID: 23135477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-lactam antibiotic resistance: a current structural perspective.
    Wilke MS; Lovering AL; Strynadka NC
    Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of bridged gamma-lactams as analogues of beta-lactam antibiotics.
    Aszodi J; Rowlands DA; Mauvais P; Collette P; Bonnefoy A; Lampilas M
    Bioorg Med Chem Lett; 2004 May; 14(10):2489-92. PubMed ID: 15109638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four further antibiotics related to olivanic acid produced by Streptomyces olivaceus: fermentation, isolation, characterisation and biosynthetic studies.
    Box SJ; Hood JD; Spear SR
    J Antibiot (Tokyo); 1979 Dec; 32(12):1239-47. PubMed ID: 317283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meeting the challenges of beta-lactamases.
    Moellering RC
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():1-8. PubMed ID: 8449834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic strategies and medicinal properties of beta-lactams.
    Kidwai M; Sapra P; Bhushan KR
    Curr Med Chem; 1999 Mar; 6(3):195-215. PubMed ID: 10219100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PS-5, a new beta-lactam antibiotic. III. Synergistic effects and inhibitory activity against a beta-lactamase.
    Okamura K; Sakamoto M; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1979 Apr; 32(4):280-6. PubMed ID: 381269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5,6-Cis-penems: broad-spectrum anti-methicillin-resistant Staphylococcus aureus beta-lactam antibiotics.
    Ishiguro M; Tanaka R; Namikawa K; Nasu T; Inoue H; Nakatsuka T; Oyama Y; Imajo S
    J Med Chem; 1997 Jul; 40(14):2126-32. PubMed ID: 9216830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383.
    Basker MJ; Boon RJ; Hunter PA
    J Antibiot (Tokyo); 1980 Aug; 33(8):878-84. PubMed ID: 6968745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactamase-mediated resistance and opportunities for its control.
    Livermore DM
    J Antimicrob Chemother; 1998 Jun; 41 Suppl D():25-41. PubMed ID: 9688449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutual pro-drugs of beta-lactam antibiotics and beta-lactamase inhibitors.
    Baltzer B; Binderup E; von Daehne W; Godtfredsen WO; Hansen K; Nielsen B; Sørensen H; Vangedal S
    J Antibiot (Tokyo); 1980 Oct; 33(10):1183-92. PubMed ID: 6969724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics.
    Medeiros AA
    Clin Infect Dis; 1997 Jan; 24 Suppl 1():S19-45. PubMed ID: 8994778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Aminothiazolyl analogues of GE2270 A: antibacterial lead finding.
    LaMarche MJ; Leeds JA; Dzink-Fox J; Gunderson K; Krastel P; Memmert K; Patane MA; Rann EM; Schmitt E; Tiamfook S; Wang B
    J Med Chem; 2011 Apr; 54(7):2517-21. PubMed ID: 21405087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-(substituted methylene)penems, potent broad spectrum inhibitors of bacterial beta-lactamase. II. Racemic furyl and thienyl derivatives.
    Broom NJ; Coleman K; Hunter PA; Osborne NF
    J Antibiot (Tokyo); 1990 Jan; 43(1):76-82. PubMed ID: 2407709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress of beta-lactam antibiotics. Special reference to monobactam (author's transl)].
    Yokota K
    Jpn J Antibiot; 1981 Dec; 34(12):1525-39. PubMed ID: 7038187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.